National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 5110 [2018-02253]
Download as PDF
<![CDATA[
5110
Federal Register / Vol. 83, No. 24 / Monday, February 5, 2018 / Notices
Dated: January 31, 2018.
John R. Graham,
Acting Assistant Secretary for Planning and
Evaluation.
[FR Doc. 2018–02211 Filed 2–2–18; 8:45 am]
BILLING CODE 4150–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
sradovich on DSK3GMQ082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Kidney, Urologic and
Hematologic Diseases D Subcommittee.
Date: February 21–22, 2018.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Barbara A. Woynarowska,
Ph.D., Scientific Review Administrator,
Review Branch, DEA, NIDDK, National
Institutes of Health, Room 7007, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301) 402–7172, woynarowskab@
niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Digestive Diseases and
Nutrition C Subcommittee.
Date: March 7–9, 2018.
Time: 6:00 p.m. to 10:30 a.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Maria E. Davila-Bloom,
Ph.D., Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 7017, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7637, davila-bloomm@
extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Diabetes,
VerDate Sep<11>2014
18:08 Feb 02, 2018
Jkt 244001
Endocrinology and Metabolic Diseases B
Subcommittee.
Date: March 7–9, 2018.
Time: 8:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: John F. Connaughton,
Ph.D., Chief, Scientific Review Branch,
Review Branch, DEA, NIDDK, National
Institutes of Health, Room 7007, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301) 594–7797, connaughtonj@
extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: January 31, 2018.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–02253 Filed 2–2–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel; Data
Archives for the BRAIN Initiative (R24) and
Standards To Define Experiments Related to
the BRAIN Initiative (R24).
Date: February 26, 2018.
Time: 12:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Vinod Charles, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6151, MSC 9606,
Bethesda, MD 20892–9606, 301–443–1606,
charlesvi@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Clinical Trial and K Awards Review Meeting.
Date: February 27, 2018.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: David I. Sommers, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
6001 Executive Blvd., Room 6154, MSC 9606,
Bethesda, MD 20892, 301–443–7861,
dsommers@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Integration and Analysis of BRAIN Initiative
Data (R24).
Date: February 28, 2018
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Vinod Charles, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6151, MSC 9606,
Bethesda, MD 20892–9606, 301–443–1606,
charlesvi@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: January 31, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–02251 Filed 2–2–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel, March
13, 2018, 4:00 p.m. to March 14, 2018,
5:00 p.m., Bethesda North Marriott
Hotel & Conference Center, 5701
Marinelli Road, North Bethesda, MD
20852 which was published in the
Federal Register on January 11, 2018, 83
FR 1378.
This meeting notice is amended to
change the meeting name from ‘‘TEP–1:
Development of Software Tools for Post
Radiation Therapy Surveillance’’ to
E:\FR\FM\05FEN1.SGM
05FEN1
]]>Agencies
[Federal Register Volume 83, Number 24 (Monday, February 5, 2018)]
[Notices]
[Page 5110]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-02253]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Initial Review Group; Kidney, Urologic and
Hematologic Diseases D Subcommittee.
Date: February 21-22, 2018.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Barbara A. Woynarowska, Ph.D., Scientific Review
Administrator, Review Branch, DEA, NIDDK, National Institutes of
Health, Room 7007, 6707 Democracy Boulevard, Bethesda, MD 20892-
5452, (301) 402-7172, w[email protected].
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Initial Review Group; Digestive Diseases and
Nutrition C Subcommittee.
Date: March 7-9, 2018.
Time: 6:00 p.m. to 10:30 a.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Maria E. Davila-Bloom, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7017, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301)
594-7637, [email protected].
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Initial Review Group; Diabetes, Endocrinology
and Metabolic Diseases B Subcommittee.
Date: March 7-9, 2018.
Time: 8:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Hotel Bethesda (Formerly Holiday Inn Select),
8120 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: John F. Connaughton, Ph.D., Chief, Scientific
Review Branch, Review Branch, DEA, NIDDK, National Institutes of
Health, Room 7007, 6707 Democracy Boulevard, Bethesda, MD 20892-
5452, (301) 594-7797, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: January 31, 2018.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-02253 Filed 2-2-18; 8:45 am]
BILLING CODE 4140-01-P
